NM_173176.3:c.*91G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_173176.3(PTK2B):​c.*91G>A variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.415 in 1,369,084 control chromosomes in the GnomAD database, including 121,505 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16105 hom., cov: 32)
Exomes 𝑓: 0.41 ( 105400 hom. )

Consequence

PTK2B
NM_173176.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.71

Publications

27 publications found
Variant links:
Genes affected
PTK2B (HGNC:9612): (protein tyrosine kinase 2 beta) This gene encodes a cytoplasmic protein tyrosine kinase which is involved in calcium-induced regulation of ion channels and activation of the map kinase signaling pathway. The encoded protein may represent an important signaling intermediate between neuropeptide-activated receptors or neurotransmitters that increase calcium flux and the downstream signals that regulate neuronal activity. The encoded protein undergoes rapid tyrosine phosphorylation and activation in response to increases in the intracellular calcium concentration, nicotinic acetylcholine receptor activation, membrane depolarization, or protein kinase C activation. This protein has been shown to bind CRK-associated substrate, nephrocystin, GTPase regulator associated with FAK, and the SH2 domain of GRB2. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTK2BNM_173176.3 linkc.*91G>A 3_prime_UTR_variant Exon 31 of 31 ENST00000346049.10 NP_775268.1 Q14289-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTK2BENST00000346049.10 linkc.*91G>A 3_prime_UTR_variant Exon 31 of 31 1 NM_173176.3 ENSP00000332816.6 Q14289-1

Frequencies

GnomAD3 genomes
AF:
0.447
AC:
67800
AN:
151766
Hom.:
16093
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.604
Gnomad AMI
AF:
0.613
Gnomad AMR
AF:
0.409
Gnomad ASJ
AF:
0.340
Gnomad EAS
AF:
0.180
Gnomad SAS
AF:
0.449
Gnomad FIN
AF:
0.308
Gnomad MID
AF:
0.402
Gnomad NFE
AF:
0.405
Gnomad OTH
AF:
0.424
GnomAD4 exome
AF:
0.411
AC:
500625
AN:
1217200
Hom.:
105400
Cov.:
18
AF XY:
0.411
AC XY:
247858
AN XY:
602548
show subpopulations
African (AFR)
AF:
0.607
AC:
16959
AN:
27962
American (AMR)
AF:
0.402
AC:
13402
AN:
33322
Ashkenazi Jewish (ASJ)
AF:
0.345
AC:
7490
AN:
21722
East Asian (EAS)
AF:
0.148
AC:
5142
AN:
34846
South Asian (SAS)
AF:
0.476
AC:
33414
AN:
70236
European-Finnish (FIN)
AF:
0.322
AC:
11714
AN:
36368
Middle Eastern (MID)
AF:
0.404
AC:
1477
AN:
3660
European-Non Finnish (NFE)
AF:
0.416
AC:
389662
AN:
937188
Other (OTH)
AF:
0.412
AC:
21365
AN:
51896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
14775
29549
44324
59098
73873
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11830
23660
35490
47320
59150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.447
AC:
67834
AN:
151884
Hom.:
16105
Cov.:
32
AF XY:
0.440
AC XY:
32675
AN XY:
74208
show subpopulations
African (AFR)
AF:
0.603
AC:
24992
AN:
41416
American (AMR)
AF:
0.409
AC:
6254
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.340
AC:
1180
AN:
3468
East Asian (EAS)
AF:
0.180
AC:
922
AN:
5126
South Asian (SAS)
AF:
0.450
AC:
2165
AN:
4812
European-Finnish (FIN)
AF:
0.308
AC:
3251
AN:
10558
Middle Eastern (MID)
AF:
0.405
AC:
119
AN:
294
European-Non Finnish (NFE)
AF:
0.405
AC:
27505
AN:
67904
Other (OTH)
AF:
0.421
AC:
889
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1838
3675
5513
7350
9188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.418
Hom.:
17678
Bravo
AF:
0.460
Asia WGS
AF:
0.349
AC:
1216
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
15
DANN
Benign
0.78
PhyloP100
3.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2271920; hg19: chr8-27316117; COSMIC: COSV53557624; COSMIC: COSV53557624; API